Yahoo Web Search

Search results

    • GSK boasts win for depemokimab in asthma trials

      GSK boasts win for depemokimab in asthma trials

      Clinical Trials Arena via Yahoo Finance· 5 hours ago

      As a result, depemokimab’s twice-yearly dosing schedule will have lots of benefits for patients including improved adherence. According to Research...